Abramson Cancer Center Support Grant
Abramson Cancer Center Support Grant
批准号:
10408409
负责人:
ROBERT H VONDERHEIDE
金额:
$20.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-01 至 2022-08-31
关键词:
AddressAdministrative SupplementAfrican AmericanAgeAlgorithmsAreaCancer CenterCancer Center Support GrantCancer EtiologyCessation of lifeClinicClinicalCodeColonoscopyColorectal AdenomaColorectal CancerCommunitiesConsumptionCountyDataDetectionDiagnosisDiseaseEffectivenessElectronic Health RecordFamily PracticeFrequenciesGoalsGuidelinesHispanicsImmunochemistryImmunohistochemistryIncidenceIncomeIndividualInstructionInternal MedicineInterventionIntestinesKnowledgeMachine LearningMalignant NeoplasmsMedicineMethodsMinorityMissionModelingOutcomePatient CarePatientsPennsylvaniaPerformancePhiladelphiaPovertyPoverty AreasPreparationPrimary Health CareProcessProgram EffectivenessPublic HealthRecording of previous eventsRelative RisksResearchResearch PersonnelResearch ProposalsResourcesRetrospective cohortRiskRisk FactorsScreening for cancerServicesTelephoneTestingTimeTrainingTransportationUnited StatesUniversitiesadenomaadherence ratebasecancer diagnosiscancer riskcohortcolon cancer screeningcolorectal cancer preventioncolorectal cancer riskcolorectal cancer screeningcommunity livingdesigneffectiveness evaluationethnic diversityethnic minority populationevidence basefeasibility testinghigh riskhigh risk populationimprovedmachine learning algorithmminority communitiesmortalitynovelpatient populationprogramsracial diversityracial minorityrisk stratificationscreeningscreening guidelinessocialsocial factorssocial health determinantssocioeconomicssuccesstransportation accessunderserved areausability
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Colorectal cancer is the 4th most common cancer diagnosed and the 2nd most common cause of cancer death
in the United States. The age-adjusted incidence of CRC in Philadelphia County – a persistently high poverty
area– is nearly 25% above the national average. Guideline-based screening for CRC via colonoscopy or fecal
immunohistochemistry (FIT) reduces CRC-associated mortality. Despite the proven benefit of regular
colonoscopy, CRC screening completion rates remain only around 50% in Philadelphia County and are
consistently 10-15% lower for African-Americans than White individuals living in Philadelphia County. Adverse
social determinants of health such as high poverty contribute to CRC screening nonadherence
disproportionately for African-American and other minority communities. Recognizing this, in 2011, Penn
Medicine created a navigation program to increase access to screening colonoscopies for patients in
underserved areas of West, South, and Southwest Philadelphia by providing services that reduce barriers to
cancer screening, including transportation assistance and detailed instructions on bowel prep. Despite initial
success in increasing colonoscopies, a key challenge in scaling this navigation program is identifying patient
populations at increased risk of CRC, who may benefit most from timely navigation. Automated machine
learning (ML) algorithms based on routine electronic health record (EHR) data accurately estimate a patient’s
relative risk of CRC. High-risk individuals may be particularly motivated to comply with disease screening
recommendations and be targeted with an effective but resource-constrained navigator program.
The overarching goals of this Administrative Supplement is to support the Abramson Cancer Center (ACC)
mission to increase colorectal cancer (CRC) screening completion among high-risk individuals living in a
persistent poverty county by designing, conducting, disseminating and evaluating an electronic health record-
based automated identification program to target effective, culturally-sensitive CRC screening navigation to
individuals who have not completed an ordered colonoscopy or fecal immunochemical test (FIT). Specifically,
the goals of this supplement are to: 1) Adapt a previously validated EHR-based machine learning algorithm to
predict CRC detection by retraining the model using data from patients seen in primary care clinics serving zip
codes with a high proportion of racial and ethnic minorities living in Philadelphia County, a persistent poverty
county; and 2) Implement and evaluate the feasibility and effectiveness of an algorithm-based CRC navigation
program to increase colorectal cancer screening among 344 patients seen at one of 7 primary care practices
within Philadelphia county who are at high risk of CRC, have uncompleted colonoscopies. Together, these
projects aim to increase evidence-based screening in order to reduce the burden of CRC among high-risk
individuals living in a persistent poverty county by utilizing evidence-based, targeted, culturally-sensitive CRC
screening navigation that in part addresses social factors that prevent colorectal cancer screening.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Abramson Cancer Center Support Grant.
-
批准号:10367691
-
项目类别:
-
资助金额:$16.25万
-
财政年份:2021
-
负责人:ROBERT H VONDERHEIDE
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:10425591
-
项目类别:
-
资助金额:$19.94万
-
财政年份:2021
-
负责人:ROBERT H VONDERHEIDE
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:10469216
-
项目类别:
-
资助金额:$36.76万
-
财政年份:2021
-
负责人:ROBERT H VONDERHEIDE
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:10372715
-
项目类别:
-
资助金额:$11.5万
-
财政年份:2021
-
负责人:ROBERT H VONDERHEIDE
-
依托单位:
Immunotherapy and Tumor Microenvironment in HIV/AIDS Cancer Patients
-
批准号:10249752
-
项目类别:
-
资助金额:$7.34万
-
财政年份:2019
-
负责人:ROBERT H VONDERHEIDE
-
依托单位:
non-AIDS defining cancers (NADCs) among aging HIV+ individuals
-
批准号:10249743
-
项目类别:
-
资助金额:$7.93万
-
财政年份:2019
-
负责人:ROBERT H VONDERHEIDE
-
依托单位:
Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients
-
批准号:10005190
-
项目类别:
-
资助金额:$64.61万
-
财政年份:2017
-
负责人:ROBERT H VONDERHEIDE
-
依托单位:
Core A: Administration
-
批准号:10005186
-
项目类别:
-
资助金额:$6.77万
-
财政年份:2017
-
负责人:ROBERT H VONDERHEIDE
-
依托单位:
Core A: Administration
-
批准号:10360420
-
项目类别:
-
资助金额:$6.77万
-
财政年份:2017
-
负责人:ROBERT H VONDERHEIDE
-
依托单位:
Program Integration
-
批准号:10360426
-
项目类别:
-
资助金额:$1.64万
-
财政年份:2017
-
负责人:ROBERT H VONDERHEIDE
-
依托单位:
Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients
-
批准号:10360423
-
项目类别:
-
资助金额:$63.93万
-
财政年份:2017
-
负责人:ROBERT H VONDERHEIDE
-
依托单位:
Program Integration
-
批准号:10005193
-
项目类别:
-
资助金额:$1.64万
-
财政年份:2017
-
负责人:ROBERT H VONDERHEIDE
-
依托单位:
Combined CD40 activation and CTLA4 blockade in melanoma
-
批准号:8084679
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2011
-
负责人:ROBERT H VONDERHEIDE
-
依托单位:
Combined CD40 activation and CTLA4 blockade in melanoma
-
批准号:8460948
-
项目类别:
-
资助金额:$31.21万
-
财政年份:2011
-
负责人:ROBERT H VONDERHEIDE
-
依托单位:
Combined CD40 activation and CTLA4 blockade in melanoma
-
批准号:8848307
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2011
-
负责人:ROBERT H VONDERHEIDE
-
依托单位:
Combined CD40 activation and CTLA4 blockade in melanoma
-
批准号:8657906
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2011
-
负责人:ROBERT H VONDERHEIDE
-
依托单位:
Combined CD40 activation and CTLA4 blockade in melanoma
-
批准号:8300098
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2011
-
负责人:ROBERT H VONDERHEIDE
-
依托单位:
Immunoregulation and immunotherapy of breast cancer
-
批准号:8193071
-
项目类别:
-
资助金额:$31.04万
-
财政年份:2005
-
负责人:ROBERT H VONDERHEIDE
-
依托单位:
Immunoregulation and immunotherapy of breast cancer
-
批准号:7729898
-
项目类别:
-
资助金额:$32.75万
-
财政年份:2005
-
负责人:ROBERT H VONDERHEIDE
-
依托单位:
Immunoregulation and immunotherapy of breast cancer
-
批准号:6969221
-
项目类别:
-
资助金额:$31.51万
-
财政年份:2005
-
负责人:ROBERT H VONDERHEIDE
-
依托单位:
海外基金